| Role |
Name |
Disclosure |
Details |
| Author | Christen M Mowad, MD, Associate Professor, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details | | Coauthor | David Hensley, MD, Mullanax Dermatology Associates, Arlington Memorial Hospital | Nothing to disclose | Details | | Coauthor | Lindsey Ann Dohse, MD, Staff Physician, Department of Dermatology, Geisinger Health System | Nothing to disclose | Details | | Medical Editor | Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania | Amgen Astellas Abbott Genentech Incyte Centocor Warner Chilcott Merck | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine | Amgen Abbott Electrical Optical Sciences Centocor | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| David Hensley, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Lindsey Ann Dohse, Coauthor |
The contributor discloses no conflict of interest. |
|